NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »           NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »          NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »

Latest News

Media Inquiries

Empowering Healthcare Providers and Patients with Genetic Testing and Genetic Counseling Solutions COLUMBIA, Md., May 15, 2024 /PRNewswire/ — The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, announces today its partnership with PreventionGenetics, a part of Exact Sciences, as its new genetic laboratory partner for […]

NEW YORK, NEW YORK , UNITED STATES, January 10, 2024 /EINPresswire.com/ — In partnership with InformedDNA® , the Hereditary Neuropathy Foundation (HNF) has added more value to their Charcot-Marie-Tooth (CMT) Genie Project — a patient-initiated at-home genetic testing program, providing faster and more equitable access to critical genetic care for the CMT community and their […]

HealthHelp, a leading specialty benefits management and care management company, and InformedDNA, the nation’s leading applied genomics solutions company, announce a new strategic partnership. This alliance extends the value of HealthHelp’s specialty benefits program portfolio with the addition of Genetic Testing Utilization Management (GTUM) through the integration of InformedDNA’s proven genomics expertise and content. The […]

Milestone is evidence of the company’s continued evolution to accelerate and increase accessibility to precision medicine St. Petersburg, FL – August 1, 2023 – InformedDNA®, the nation’s leading applied genomics solutions company, announced today its acquisition of gWell Health, a digital health, genomics, and wellness company. InformedDNA’s deep genomic expertise partnered with gWell’s robust technology […]

How can we help?

Reach out today to discover how our dynamic solutions can help your organization make informed decisions, manage utilization of genetic tests, and control costs for cost-effective enhanced patient care and better outcomes for all.

×